Latest Regulatory News

The Takeovers Panel has modified its restrictions on ARN Media’s voting rights over Southern Cross Media shares, gradually lifting limitations starting July 2025. This change reshapes the shareholder voting landscape ahead of key resolutions.

Loyal Metals Ltd has had its trading suspension lifted immediately after announcing a proposed acquisition and addressing a price query, signaling renewed market activity.

Loyal Metals Limited has addressed unusual trading activity by announcing its acquisition of an option on the Highway Reward Copper Gold Mine, following an ASX price query and a trading halt.

Loyal Metals has secured a binding option to acquire the Highway Reward Copper Gold Mine, one of the world’s highest-grade copper assets, marking a significant step in its 2025 plan to expand into copper amid soaring commodity prices.

Macarthur Minerals has updated the timetable for its pro-rata renounceable rights issue, providing shareholders with more time to participate in the A$2 million capital raise. The offer terms remain unchanged as the company awaits regulatory approval for a supplementary prospectus.

SRJ Technologies Group has voluntarily suspended its ASX trading as it prepares for a pivotal capital raising and shareholder meeting to secure its financial future.

Kinterra Capital has lodged a formal application with the Takeovers Panel, contesting Central Asia Metals’ takeover tactics and $10 million placement in New World Resources. The dispute raises questions about market fairness and control of the mineral explorer.

TechGen Metals has secured a Heritage Protection Agreement with the Jaru People, unlocking exploration licence grants and enabling planned drilling at its Blue Devil copper-gold-silver project in Western Australia.

Horseshoe Metals has secured crucial Direct Shipping Ore mining approval for its Horseshoe Lights Copper-Gold Project, setting the stage for imminent production and early revenue generation from high-grade copper stockpiles.

Vitasora Health has secured approximately A$11 million in capital to accelerate its expansion in the US remote patient monitoring market, highlighted by an upgraded contract with TPAC covering 15,000 patients. The company targets a USD 18 million annual recurring revenue run-rate by late 2026.

Horseshoe Metals secures $851,000 through a share placement and converts nearly $650,000 of debt into equity, aiming to accelerate development at its Horseshoe Lights Copper-Gold Project and fund exploration across Australia.

Prescient Therapeutics has opened a Share Purchase Plan to raise up to $7 million, offering shareholders discounted shares to fund the Phase 2 development of its targeted cancer therapy PTX-100.